Literature DB >> 7232833

Endotoxin-induced tumor necrosis factor.

H F Oettgen, E A Carswell, R L Kassel, N Fiore, B Williamson, M K Hoffmann, K Haranaka, L J Old.   

Abstract

The serum of BCG-infected mice treated with endotoxin contains a substance (tumor necrosis factor, TNF) which mimics the tumor-necrotizing action of endotoxin itself. TNF is not residual endotoxin, but a factor released from host cells, probably macrophages. TNF induced in the same way in rats and rabbits also causes necrosis of transplanted murine tumors. Unlike endotoxin, TNF is toxic in vitro for neoplastic murine and human cell lines but not for mouse embryo culture. TNF has striking effects on immunologic reactions in vitro, some like those of endotoxin and others unlike those of endotoxin. TNF is a glycoprotein; its molecular weight is less than 70,000. Highly purified preparations do not contain lysosomal or nonlysosomal serum enzymes, interferon or prostaglandin E1.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7232833     DOI: 10.1007/978-3-642-81491-4_32

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  14 in total

1.  TNF-derived peptides inhibit tumour growth and metastasis through cytolytic effects on tumour lymphatics.

Authors:  W Lu; Y Wang; Q Zhang; S Owen; M Green; T Ni; M Edwards; Y Li; L Zhang; A Harris; J-L Li; D G Jackson; S Jiang
Journal:  Clin Exp Immunol       Date:  2019-07-03       Impact factor: 4.330

Review 2.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

3.  Bioassay for tumor necrosis factors-alpha and -beta.

Authors:  T J Evans
Journal:  Mol Biotechnol       Date:  2000-07       Impact factor: 2.695

4.  The Physiological Role of Tumor Necrosis Factor in Human Immunity and Its Potential Implications in Spinal Manipulative Therapy: A Narrative Literature Review.

Authors:  Liang Zhang; Chao Hua Yao
Journal:  J Chiropr Med       Date:  2016-05-26

5.  Antitumour activity of endotoxin, concanavalin A and poly I: C and their ability to elicit tumour necrosis factor, cytostatic factors, and interferon in vivo.

Authors:  N Bloksma; C F Kuper; F M Hofhuis; B Benaissa-Trouw; J M Willers
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

6.  Acid sphingomyelinase involvement in tumor necrosis factor alpha-regulated vascular and steroid disruption during luteolysis in vivo.

Authors:  Luiz E Henkes; Brian T Sullivan; Maureen P Lynch; Richard Kolesnick; Danielle Arsenault; Mark Puder; John S Davis; Bo R Rueda
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-27       Impact factor: 11.205

7.  Krüppel-like factor 3 (KLF3) suppresses NF-κB-driven inflammation in mice.

Authors:  Alexander J Knights; Lu Yang; Manan Shah; Laura J Norton; Gamran S Green; Elizabeth S Stout; Emily J Vohralik; Merlin Crossley; Kate G R Quinlan
Journal:  J Biol Chem       Date:  2020-03-25       Impact factor: 5.157

8.  Induction of tumor necrosis factor by Legionella pneumophila.

Authors:  D K Blanchard; J Y Djeu; T W Klein; H Friedman; W E Stewart
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

9.  Role of first stimulating agents in the production of tumor necrosis factor.

Authors:  K Haranaka; N Satomi; A Sakurai; R Haranaka
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

10.  Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters.

Authors:  Patrycja Koszałka; Ewa Szmit; Andrzej Myśliwski; Jacek Bigda
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-07-23       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.